2022
Assessment of Photodynamic Therapy Services Performed Among Medicare Beneficiaries from 2018 to 2019.
Gronbeck C, Hine A, Cohen J, Feng H. Assessment of Photodynamic Therapy Services Performed Among Medicare Beneficiaries from 2018 to 2019. The Journal Of Clinical And Aesthetic Dermatology 2022, 15: 37-39. PMID: 36381185, PMCID: PMC9651150.Peer-Reviewed Original ResearchMedicare beneficiariesNon-physician cliniciansOther Supplier Public Use FileNon-metropolitan settingsPublic Use FilePhotodynamic therapyHealthcare professionalsPractice settingsMedicare populationNational levelMedicare PhysicianMedicarePractice patternsPremalignant skin lesionsInfluence service performanceUtilization trendsTreatment modalitiesSkin lesionsBeneficiariesServicesSevere lesionsDeliveryHealthcareLesionsPractice
2020
Early Adoption of Dupilumab in the Medicare Population in 2017.
Cheraghlou S, Cohen JM. Early Adoption of Dupilumab in the Medicare Population in 2017. The Yale Journal Of Biology And Medicine 2020, 93: 675-677. PMID: 33380928, PMCID: PMC7757055.Peer-Reviewed Original ResearchConceptsAtopic dermatitisRural-Urban Continuum CodesMedicare populationHealth Statistics Urban-Rural Classification SchemeInjectable biologicsSevere atopic dermatitisRetrospective cohort studyCohort studyPatient outcomesDupilumabFirst drugMedicare Provider UtilizationFDA approvalUtilization trendsFirst FDAFuture interventionsProvider UtilizationPotential targetBiologicsDisease treatmentPatientsTreatmentFirst yearMore rural regionsContinuum Codes